Science policy implications to DNA recombinant molecule researchU.S. Government Printing Office, 1977 - 1293 pages |
From inside the book
Results 1-3 of 66
Page 818
... decisions to be made . That is , what is to be the purpose of the decision ? What is its scope ? How inclusive is it to be ? Is the decision to be made chiefly a scientific one , or political , or ethical , or is it an operational ...
... decisions to be made . That is , what is to be the purpose of the decision ? What is its scope ? How inclusive is it to be ? Is the decision to be made chiefly a scientific one , or political , or ethical , or is it an operational ...
Page 822
... decision process ? Intensification of a recombinant DNA - type issue could make this a very real question indeed . The very social forces that produce the demand for a broader decision base also produce the demand that decisions about ...
... decision process ? Intensification of a recombinant DNA - type issue could make this a very real question indeed . The very social forces that produce the demand for a broader decision base also produce the demand that decisions about ...
Page 823
... decision making and also specify the criteria for selection as well as the decision making procedures . There is a less precipitous approach to new answers to the Step 3 question : collaboration and inventiveness depend on the extent to ...
... decision making and also specify the criteria for selection as well as the decision making procedures . There is a less precipitous approach to new answers to the Step 3 question : collaboration and inventiveness depend on the extent to ...
Contents
Technology Cambridge Mass | 133 |
Dr Ethan Signer professor of biology Massachusetts Institute | 139 |
Dr David Baltimore American Cancer Society research professor | 158 |
1 other sections not shown
Common terms and phrases
activities agencies amendment American analysis antibiotic resistance antibiotics anticodon Association bacteria bacterium basic benefits biohazards biological containment cancer cells Chairman THORNTON chemical citizen coli Committee concern conduct Congress decision discussion disease DNA recombinant drug environment environmental example experiments facilities Federal Fort Detrick Fredrickson freedom genes genetic engineering George Wald going groups hazards hearings human industry insulin interest involved issue knowledge laboratory legislation licensing Lilly ment microorganisms molecular molecular biology molecule research National nature NIH guidelines nuclear organisms patent pathogenic PIECZENIK plasmid political possible potential present problem procedures production protection protein question recombinant DNA molecules recombinant DNA research recombinant DNA technology regulation require responsibility risk risk-benefit risk-benefit analysis safety scientific community scientists Secretary Sinsheimer social society specific statement strains Subcommittee suggested testimony Thank things tion tRNA University viruses